293 related articles for article (PubMed ID: 3500791)
1. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.
Di Fiore PP; Pierce JH; Fleming TP; Hazan R; Ullrich A; King CR; Schlessinger J; Aaronson SA
Cell; 1987 Dec; 51(6):1063-70. PubMed ID: 3500791
[TBL] [Abstract][Full Text] [Related]
2. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.
Velu TJ; Beguinot L; Vass WC; Willingham MC; Merlino GT; Pastan I; Lowy DR
Science; 1987 Dec; 238(4832):1408-10. PubMed ID: 3500513
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
Kokai Y; Myers JN; Wada T; Brown VI; LeVea CM; Davis JG; Dobashi K; Greene MI
Cell; 1989 Jul; 58(2):287-92. PubMed ID: 2568888
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts.
Lu Z; Hornia A; Joseph T; Sukezane T; Frankel P; Zhong M; Bychenok S; Xu L; Feig LA; Foster DA
Mol Cell Biol; 2000 Jan; 20(2):462-7. PubMed ID: 10611224
[TBL] [Abstract][Full Text] [Related]
5. Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells.
Ono M; Nakayama Y; Princler G; Gopas J; Kung HF; Kuwano M
Exp Cell Res; 1992 Dec; 203(2):456-65. PubMed ID: 1459205
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
Chen P; Xie H; Sekar MC; Gupta K; Wells A
J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor induces glucose storage in transgenic 3T3-L1 adipocytes overexpressing epidermal growth factor receptors.
Van Epps-Fung M; Hardy RW; Williford J; Gupta K; Wells A
Diabetes; 1996 Nov; 45(11):1619-25. PubMed ID: 8866569
[TBL] [Abstract][Full Text] [Related]
8. TGFalpha is required for full expression of the transformed growth phenotype of NIH 3T3 cells overexpressing ornithine decarboxylase.
Geng H; Naylor PH; Dosescu J; Skunca M; Majumdar AP; Moshier JA
Carcinogenesis; 2000 Apr; 21(4):567-72. PubMed ID: 10753187
[TBL] [Abstract][Full Text] [Related]
9. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2.
Zhang K; Sun J; Liu N; Wen D; Chang D; Thomason A; Yoshinaga SK
J Biol Chem; 1996 Feb; 271(7):3884-90. PubMed ID: 8632008
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane signalling at epidermal growth factor receptors overexpressed in NIH 3T3 cells. Phosphoinositide hydrolysis, cytosolic Ca2+ increase and alkalinization correlate with epidermal-growth-factor-induced cell proliferation.
Pandiella A; Beguinot L; Velu TJ; Meldolesi J
Biochem J; 1988 Aug; 254(1):223-8. PubMed ID: 2845945
[TBL] [Abstract][Full Text] [Related]
11. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts.
Riedel H; Massoglia S; Schlessinger J; Ullrich A
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1477-81. PubMed ID: 3257824
[TBL] [Abstract][Full Text] [Related]
12. The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.
Finzi E; Fleming T; Segatto O; Pennington CY; Bringman TS; Derynck R; Aaronson SA
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3733-7. PubMed ID: 3035551
[TBL] [Abstract][Full Text] [Related]
13. EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells.
Gopas J; Ono M; Princler G; Smith MR; Tainsky MA; Siddiqui MA; Wishniak O; Segal S; Kuwano M; Kung HF
Cell Mol Biol; 1992 Sep; 38(6):605-14. PubMed ID: 1303308
[TBL] [Abstract][Full Text] [Related]
14. Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.
Brown KD; Blakeley DM; Roberts P; Avery RJ
Biochem J; 1985 Jul; 229(1):119-25. PubMed ID: 2994627
[TBL] [Abstract][Full Text] [Related]
15. EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene.
Ishikawa J; Maeda S; Sugiyama T; Nishimura R; Mizoguchi A; Kamidono S
Int J Cancer; 1989 Dec; 44(6):1000-4. PubMed ID: 2606569
[TBL] [Abstract][Full Text] [Related]
16. EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line.
Moroni MC; Willingham MC; Beguinot L
J Biol Chem; 1992 Feb; 267(4):2714-22. PubMed ID: 1733967
[TBL] [Abstract][Full Text] [Related]
17. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
18. Two independent mechanisms for escaping epidermal growth factor-mediated growth inhibition in epidermal growth factor receptor-hyperproducing human tumor cells.
Hirai M; Gamou S; Minoshima S; Shimizu N
J Cell Biol; 1988 Aug; 107(2):791-9. PubMed ID: 2458359
[TBL] [Abstract][Full Text] [Related]
19. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
[TBL] [Abstract][Full Text] [Related]
20. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
Moscatelli D; Quarto N
J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
